Beone Medicines
Clinical trials sponsored by Beone Medicines, explained in plain language.
-
New pill tested for hard-to-treat cancers
Disease control TerminatedThis early-stage study tested a new pill called BG-89894 in 29 adults with advanced solid tumors that have a specific genetic change (MTAP deletion). The main goals were to check the drug's safety, find the best dose, and see if it shows any signs of shrinking tumors. The study w…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
Experimental lung cancer drug shows promise but trial halted early
Disease control TerminatedThis early-stage study tested a new drug, BG-60366, designed to break down a faulty protein (mutant EGFR) that drives growth in some lung cancers. The trial aimed to find a safe dose and see if the drug could shrink tumors in people with advanced non-small cell lung cancer that h…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 26, 2026 03:52 UTC
-
New drug combo tested for Hard-to-Treat cancers
Disease control TerminatedThis early-stage study tested a new drug called BGB-R046, alone or with another drug (tislelizumab), in 42 people with advanced solid tumors that had stopped responding to standard treatments. The main goals were to check safety and find the right dose. The study was terminated e…
Phase: PHASE1 • Sponsor: BeOne Medicines • Aim: Disease control
Last updated May 22, 2026 13:53 UTC